Skip to main content

Interventions to Redesign Patient Care Do Not Improve Outcomes

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 2, 2023.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 1, 2023 -- Interventions to redesign care for hospitalized patients are not associated with improved patient outcomes, according to a study published online Oct. 31 in the Annals of Internal Medicine.

Kevin J. O'Leary, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined the effect of interventions to redesign hospital care delivery on teamwork and patient outcomes in a pragmatic controlled trial conducted in medical units at four U.S. hospitals. The primary outcomes were teamwork climate among health care professionals and patient-experienced adverse events.

The researchers found that the median teamwork climate score was higher after than before the intervention only for the 77 nurses among 155 professionals who completed pre- and postintervention surveys (median score, 88.0 versus 80.0). Among the 3,773 patients, the percentage with at least one adverse event was higher after than before the intervention (change, 1.61 percentage points) in control units. Compared with before the intervention, the percentage of patients with at least one adverse event after the intervention was similar in intervention units (change, 0.43 percentage points). No significant difference in change was seen in a difference-in-differences analysis. No differences were seen in length of stay, readmissions, or patient experience.

"Health care leaders should consider our findings in the context of their improvement priorities before implementing similar interventions," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.